Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
Reducing the long-term morbidity in testicular cancer survivors represents a major area of interest. External beam radiation therapy and systemic chemotherapy are established treatments for seminoma; however, they are associated with late toxicities such as cardiovascular disease, insulin resistance...
Saved in:
Main Authors: | Brian Hu, Siamak Daneshmand |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2018/7978958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hospital Surgical Volume, Utilization, Costs and Outcomes of Retroperitoneal Lymph Node Dissection for Testis Cancer
by: Hua-yin Yu, et al.
Published: (2012-01-01) -
A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer
by: Zeyad R. Schwen, et al.
Published: (2018-01-01) -
Metastatic Malignant Melanoma of the Inguinal Lymph Node with Unknown Primary Lesion
by: Sherif Ali Eltawansy, et al.
Published: (2015-01-01) -
Primary Retroperitoneal Approach to the Superior Mesenteric Vessels in Minimally Invasive Surgical Treatment of Right Colon Cancer with D3 Lymph Node Dissection. Technique and First Short-Term Outcomes
by: S. K. Efetov, et al.
Published: (2024-12-01) -
Paraneoplastic Dermatomyositis Associated with Metastatic Seminoma
by: Hidekazu Yoshie, et al.
Published: (2016-01-01)